BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 38267771)

  • 1. Unraveling Emerging Anal Cancer Clinical Biomarkers from Current Immuno-Oncogenomics Advances.
    Iseas S; Mariano G; Gros L; Baba-Hamed N; De Parades V; Adam J; Raymond E; Abba MC
    Mol Diagn Ther; 2024 Mar; 28(2):201-214. PubMed ID: 38267771
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive genomic profiling of anal squamous cell carcinoma reveals distinct genomically defined classes.
    Chung JH; Sanford E; Johnson A; Klempner SJ; Schrock AB; Palma NA; Erlich RL; Frampton GM; Chalmers ZR; Vergilio J; Rubinson DA; Sun JX; Chmielecki J; Yelensky R; Suh JH; Lipson D; George TJ; Elvin JA; Stephens PJ; Miller VA; Ross JS; Ali SM
    Ann Oncol; 2016 Jul; 27(7):1336-41. PubMed ID: 27052656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic Landscape of Primary and Recurrent Anal Squamous Cell Carcinomas in Relation to HPV Integration, Copy-Number Variation, and DNA Damage Response Genes.
    Aldersley J; Lorenz DR; Mouw KW; D'Andrea AD; Gabuzda D
    Mol Cancer Res; 2021 Aug; 19(8):1308-1321. PubMed ID: 33883185
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomic Evolution after Chemoradiotherapy in Anal Squamous Cell Carcinoma.
    Mouw KW; Cleary JM; Reardon B; Pike J; Braunstein LZ; Kim J; Amin-Mansour A; Miao D; Damish A; Chin J; Ott PA; Fuchs CS; Martin NE; Getz G; Carter S; Mamon HJ; Hornick JL; Van Allen EM; D'Andrea AD
    Clin Cancer Res; 2017 Jun; 23(12):3214-3222. PubMed ID: 27852700
    [No Abstract]   [Full Text] [Related]  

  • 5. Whole-exome sequencing identified mutational profiles of squamous cell carcinomas of anus.
    Shin S; Park HC; Kim MS; Han MR; Lee SH; Jung SH; Lee SH; Chung YJ
    Hum Pathol; 2018 Oct; 80():1-10. PubMed ID: 29555573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of anal intraepithelial neoplasia and anal squamous cell carcinoma at a tertiary referral centre with a dedicated infectious diseases unit: an 18-year review.
    Power Foley M; Kelly ME; Kerr C; Kennedy C; Gallagher D; Gillham C; Mehigan BJ; McCormick PH; Bergin C; Larkin JO
    Int J Colorectal Dis; 2020 Oct; 35(10):1855-1864. PubMed ID: 32500433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular and genomic characterisation of a panel of human anal cancer cell lines.
    Guerra GR; Kong JC; Millen RM; Read M; Liu DS; Roth S; Sampurno S; Sia J; Bernardi MP; Chittleborough TJ; Behrenbruch CC; Teh J; Xu H; Haynes NM; Yu J; Lupat R; Hawkes D; Di Costanzo N; Tothill RW; Mitchell C; Ngan SY; Heriot AG; Ramsay RG; Phillips WA
    Cell Death Dis; 2021 Oct; 12(11):959. PubMed ID: 34663790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenic alterations in PIK3CA and KMT2C are frequent and independent prognostic factors in anal squamous cell carcinoma treated with salvage abdominoperineal resection.
    Hamza A; Masliah-Planchon J; Neuzillet C; Lefèvre JH; Svrcek M; Vacher S; Bourneix C; Delaye M; Goéré D; Dartigues P; Samalin E; Hilmi M; Lazartigues J; Girard E; Emile JF; Rigault E; Dangles-Marie V; Rioux-Leclercq N; de la Fouchardière C; Tougeron D; Casadei-Gardini A; Mariani P; Peschaud F; Cacheux W; Lièvre A; Bièche I
    Int J Cancer; 2024 Feb; 154(3):504-515. PubMed ID: 37908048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of CYP2D6 copy number variants as prognostic biomarker in localized anal squamous cell carcinoma.
    Trilla-Fuertes L; Gámez-Pozo A; Nogué M; Busquier I; Arias F; López-Campos F; Fernández-Montes A; Ruiz A; Velázquez C; Martín-Bravo C; Pérez-Ruiz E; Asensio E; Hernández-Yagüe X; Rodrigues A; Ghanem I; López-Vacas R; Hafez A; Arias P; Dapía I; Solís M; Dittmann A; Ramos R; Llorens C; Maurel J; Campos-Barros Á; Fresno Vara JÁ; Feliu J
    Cancer; 2023 Aug; 129(16):2581-2592. PubMed ID: 37096763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignancies diagnosed before and after anal squamous cell carcinomas: A SEER registry analysis.
    Jani KS; Lu SE; Murphy JD; Romesser PB; Jethwa KR; Li D; Chundury A; Wu AJ; Hathout L; Hallemeier CL; Jabbour SK
    Cancer Med; 2021 Jun; 10(11):3575-3583. PubMed ID: 33960690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The importance of anal cancer screening and high-resolution anoscopy to gastroenterology practice.
    Bull-Henry K; Morris B; Buchwald UK
    Curr Opin Gastroenterol; 2020 Sep; 36(5):393-401. PubMed ID: 32701604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High IDO1 Expression Is Associated with Poor Outcome in Patients with Anal Cancer Treated with Definitive Chemoradiotherapy.
    Mitra D; Horick NK; Brackett DG; Mouw KW; Hornick JL; Ferrone S; Hong TS; Mamon H; Clark JW; Parikh AR; Allen JN; Ryan DP; Ting DT; Deshpande V; Wo JY
    Oncologist; 2019 Jun; 24(6):e275-e283. PubMed ID: 30755500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV and anal cancer in HIV-infected individuals: a review.
    Schim van der Loeff MF; Mooij SH; Richel O; de Vries HJ; Prins JM
    Curr HIV/AIDS Rep; 2014 Sep; 11(3):250-62. PubMed ID: 24990810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Systematic Review and Meta-Analysis of Prognostic Biomarkers in Anal Squamous Cell Carcinoma Treated With Primary Chemoradiotherapy.
    Parwaiz I; MacCabe TA; Thomas MG; Messenger DE
    Clin Oncol (R Coll Radiol); 2019 Dec; 31(12):e1-e13. PubMed ID: 31301958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Updated Review on Imaging and Staging of Anal Cancer-Not Just Rectal Cancer.
    Congedo A; Mallardi D; Danti G; De Muzio F; Granata V; Miele V
    Tomography; 2023 Sep; 9(5):1694-1710. PubMed ID: 37736988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive multiplatform biomarker analysis of 199 anal squamous cell carcinomas.
    Smaglo BG; Tesfaye A; Halfdanarson TR; Meyer JE; Wang J; Gatalica Z; Reddy S; Arguello D; Boland PM
    Oncotarget; 2015 Dec; 6(41):43594-604. PubMed ID: 26498363
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOLFCIS Treatment and Genomic Correlates of Response in Advanced Anal Squamous Cell Cancer.
    Mondaca S; Chatila WK; Bates D; Hechtman JF; Cercek A; Segal NH; Stadler ZK; Varghese AM; Kundra R; Capanu M; Shia J; Schultz N; Saltz L; Yaeger R
    Clin Colorectal Cancer; 2019 Mar; 18(1):e39-e52. PubMed ID: 30316684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On the etiology of anal squamous carcinoma.
    Frisch M
    Dan Med Bull; 2002 Aug; 49(3):194-209. PubMed ID: 12238281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anal squamous cell carcinoma - State of the art management and future perspectives.
    Martin D; Balermpas P; Winkelmann R; Rödel F; Rödel C; Fokas E
    Cancer Treat Rev; 2018 Apr; 65():11-21. PubMed ID: 29494827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction between IGF2-PI3K axis and cancer-associated-fibroblasts promotes anal squamous carcinogenesis.
    Cacheux W; Lièvre A; Richon S; Vacher S; El Alam E; Briaux A; El Botty R; Mariani P; Buecher B; Schnitzler A; Barbazan J; Roman-Roman S; Bièche I; Dangles-Marie V
    Int J Cancer; 2019 Oct; 145(7):1852-1859. PubMed ID: 30714617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.